International Breast Center
About
In the field of oncology, one question is asked time and again: What is the most effective strategy in the fight against cancer?One powerful answer remains constant: Knowledge.
At GMI, we believe that knowledge—gained through research, innovation, and clinical expertise—is the cornerstone of progress in cancer care. Patients from around the world seek out our center to benefit from new and effective therapies, often well before they become standard treatments elsewhere. Through access to cutting-edge drugs, personalized treatment strategies, and a collaborative, international network of specialists, we empower patients with the best that modern oncology has to offer.
In addition, we are proud to have established international benchmarks in plastic and reconstructive breast surgery. Our innovations in surgical techniques—including advanced implant procedures, breast reduction, and reconstructive approaches tailored to oncologic needs—have shaped new global standards in the field.
Whether it’s through precision medicine, minimally invasive procedures, or patient-centered innovations in surgery, our mission remains clear: to combine the most advanced medical knowledge with compassion and care to deliver the best possible outcomes.
Why Choose the GMI:
Chairman, Interdisciplinary Breast Unit – German Medical Institute, LimassolExtraordinary Professor, Charité – Humboldt University Berlin
Prof. Dr. Kümmel is a globally respected leader in breast cancer research, clinical care, and surgical innovation. He currently serves as Chairman of the Interdisciplinary Breast Unit at the German Medical Institute (GMI) in Limassol, where he oversees all aspects of diagnosis, treatment, and clinical research related to breast cancer.
In addition to his leadership role at GMI, Prof. Kümmel heads breast cancer research programs at Germany’s largest Women’s Cancer Center, where he directs Clinical Investigations and Trials. His work focuses on translating cutting-edge research into practice, helping to shape the future of breast cancer treatment.
Prof. Kümmel is an Executive Board Member of the Gynaecological Oncology Working Group (AGO) and Scientific Director of the West German Study Group (WSG), one of Europe’s leading academic breast cancer research networks. Within the AGO, he also serves on the Organ Commission (AGO Mamma) and is the appointed speaker for its Commission on Integrative Medicine (AGIMed).
His academic credentials include appointment as an Extraordinary Professor at the Medical School of Charité – Humboldt University Berlin, where he also earned his medical degree in 1997. He completed his PhD at University Hospital Essen in 2008.
Prof. Kümmel is actively engaged with major international oncology organizations. He is a faculty member and Scientific Committee member for Breast Cancer at the European Society for Medical Oncology (ESMO). His surgical expertise is reflected through his membership in the Scientific Board of Oncoplastic Breast Surgery (OPBC) and various national and international breast cancer symposia committees.
As Head of Clinical Investigations and Trials at Essen-Mitte Clinics, Prof. Kümmel has served as:
Chief Investigator in 33 national and international Phase I–III trials
Principal Investigator
